Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | EviCore by Evernorth | NovoSeven RT (coagulation factor VIIa [recombinant]) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Nexviazyme (avalglucosidase alfa-ngpt) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Natalizumab Products (Tysabri, Tyruko) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Naglazyme (galsulfase) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Myobloc (rimabotulinumtoxinB) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Monoferric (ferric derisomaltose) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Mircera (methoxy polyethylene glycol-epoetin beta) Injection | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Mepsevii (vestronidase alfa-vjbk) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Luxturna (voretigene neparvovec-rzyl) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Lumizyme (alglucosidase alfa) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Loargys (pegzilarginase-nbln) Injection | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Liraglutide Injection (Saxenda, generic) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Leuprolide acetate (Fensolvi, Lupron Depot-PED, Lupron Depot) Non-oncology | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Leqvio (inclisiran subcutaneous injection) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Leqembi (lecanemab-irmb) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Lemtrada (alemtuzumab) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Lanreotide (Somatuline Depot, generic) Injection-non oncology | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Lamzede (velmanase alfa-tycv) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Krystexxa (pegloticase) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Kisunla (donanemab-azbt) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Kanuma (sebelipase alfa) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Kalbitor (ecallantide) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Izervay (avacincaptad pegol intravitreal solution) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Itvisma (onasemnogene abeparvovec-brve) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Intravenous Immune Globulins (Alyglo, Asceniv, Bivigam, Flebogamma, Gammagard Liquid, Gammagard Liquid ERC, Gammagard S/D, Gammaked, Gammaplex, Gamunex-C, Octagam, Panzyga, Privigen, Qivigy, Yimmugo) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Injectafer (ferric carboxymaltose) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Infliximab Intravenous (Remicade, Inflectra, Renflexis, Avsola, Infliximab) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Imaavy (nipocalimab-aahu intravenous infusion) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Ilumya (tildrakizumab-asmn) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Ilaris (canakinumab) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | iDose TR (travoprost intracameral implant) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Hyaluronic Acid Intra-articular Products Medicare Advantage | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Hyaluronic Acid Intra-articular Products | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Hemlibra (emicizumab-kxwh) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Hemgenix (etranacogene dezaparvovec-drlb) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Givlaari (givosiran) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Gazyva (obinutuzumab) Injection Non-oncology | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Gamifant (emapalumab-lzsg) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Filgrastim Products (Neupogen, Nivestym, Nypozi, Releuko, Zarxio) Non-oncology | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Fibrinogen Products (RiaSTAP, Fibryga) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Feraheme (ferumoxytol) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | FEIBA (anti-inhibitor coagulant complex) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Fasenra (benralizumab) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Factor XIII Products Corifact (factor XIII concentrate [human]) Tretten (coagulation factor XIII A-subunit [recombinant]) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Factor VIII Products | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Factor IX Products | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Fabrazyme (agalsidase beta) | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Exondys 51 (eteplirsen) | Metadata changed |
| Aug 2, 2026 | EviCore by Evernorth | Exdensur (depemokimab-ulaa) Injection | New policy |
| Aug 2, 2026 | EviCore by Evernorth | Evkeeza (evinacumab-dgnb) | Metadata changed |